NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
At close: Jan 14, 2026
NAVCO Pharmaceuticals Market Cap
NAVCO Pharmaceuticals has a market cap or net worth of CAD 285.35 thousand as of January 20, 2026.
Market Cap
285.35K
Enterprise Value
364.87K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since April 18, 2023, NAVCO Pharmaceuticals's market cap has decreased from 18.16M to 285.35K, a decrease of -98.43%. That is a compound annual growth rate of -77.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 285.35K | -50.00% |
| Dec 30, 2025 | 570.70K | -33.33% |
| Dec 17, 2024 | 856.04K | -15.14% |
| Dec 22, 2023 | 1.01M | -94.44% |
| Apr 18, 2023 | 18.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |